AZN logo

AstraZeneca (AZN) Revenue

Annual Revenue

$54.07 B
+$8.26 B+18.03%

December 1, 2024

Summary

Performance

1-Year Change

+18.03%

3-Year Change

+44.51%

5-Year Change

+121.76%

15-Year Change

+140.7%

AZN Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.31%
AZN annual revenue is higher than 98.31% of companies in Healthcare sector

Analysts Estimate

$56.95 B
AZN annual revenue is currently -5.05% lower than the consensus analysts' forecast

High & Low

All-time High

$54.07 B
AZN annual revenue is currently at an all-time high

3-Year Low

$37.42 B
AZN annual revenue is currently +44.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
AZN previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
AZN next annual earnings announcement has not yet been scheduled

OtherAZNprofitabilitymetrics:

Annual EPS

$2.25
AZN annual earnings per share is $2.25

Annual Net Income

$7.04 B
AZN annual net profit is $7.04 billion

Annual Operating Profit

$10.00 B
AZN annual operating income is $10.00 billion

Annual Gross Profit

$43.87 B
AZN annual gross profit is $43.87 billion

Quarterly Revenue

$13.56 B
+$627.00 M+4.85%

September 30, 2024

Summary

Performance

3-Month Change

+4.85%

1-Year Change

+18.04%

3-Year Change

+25.94%

5-Year Change

+25.94%

AZN Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.12%
AZN quarterly revenue is higher than 98.12% of companies in Healthcare sector

Analysts Estimate

$14.21 B
AZN quarterly revenue is currently -4.55% lower than the consensus analysts' forecast

High & Low

All-time High

$13.56 B
AZN quarterly revenue is currently at an all-time high

3-Year Low

$10.77 B
AZN quarterly revenue is currently +25.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$10.48 B
AZN quarterly gross profit is $10.48 billion

Quarterly Operating Profit

$2.11 B
AZN quarterly operating income is $2.11 billion

Quarterly Net Income

$1.43 B
AZN quarterly net profit is $1.43 billion

Quarterly EPS

$0.46
AZN quarterly earnings per share is $0.46

TTM Revenue

$51.21 B
+$2.07 B+4.22%

September 30, 2024

Summary

Performance

3-Month Change

+4.22%

1-Year Change

+13.81%

3-Year Change

+16.28%

5-Year Change

+16.28%

AZN TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.88%
AZN TTM revenue is higher than 97.88% of companies in Healthcare sector

Analysts Estimate

$53.39 B
AZN TTM revenue is currently -4.10% lower than the consensus analysts' forecast

High & Low

All-time High

$51.21 B
AZN TTM revenue is currently at an all-time high

3-Year Low

$37.42 B
AZN TTM revenue is currently +36.85% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

OtherAZNprofitabilitymetrics:

TTM Gross Profit

$41.42 B
AZN TTM gross profit is $41.42 billion

TTM Operating Profit

$10.76 B
AZN TTM operating income is $10.76 billion

TTM Net Income

$6.50 B
AZN TTM net profit is $6.50 billion

TTM EPS

$2.08
AZN TTM earnings per share is $2.08

AZN Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+18.0%+18.0%+13.8%
3 y3 years+44.5%+25.9%+16.3%
5 y5 years+121.8%+25.9%+16.3%

AZN Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+44.5%at high+25.9%at high+36.9%
5 y5-yearat high+121.8%at high+116.2%at high+110.0%
alltimeall timeat high+796.0%at high+784.5%at high+2828.6%

AstraZeneca Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$54.07 B(+18.0%)
-
-
Sep 2024
-
$13.56 B(+4.8%)
$51.21 B(+4.2%)
Jun 2024
-
$12.94 B(+2.0%)
$49.13 B(+3.2%)
Mar 2024
-
$12.68 B(+5.4%)
$47.61 B(+3.9%)
Dec 2023
$45.81 B(+3.3%)
$12.02 B(+4.6%)
$45.81 B(+1.8%)
Sep 2023
-
$11.49 B(+0.7%)
$44.99 B(+1.1%)
Jun 2023
-
$11.42 B(+4.9%)
$44.48 B(+1.5%)
Mar 2023
-
$10.88 B(-2.9%)
$43.84 B(-1.2%)
Dec 2022
$44.35 B(+18.5%)
$11.21 B(+2.0%)
$44.35 B(-1.8%)
Sep 2022
-
$10.98 B(+2.0%)
$45.15 B(+2.5%)
Jun 2022
-
$10.77 B(-5.4%)
$44.04 B(+6.1%)
Mar 2022
-
$11.39 B(-5.2%)
$41.49 B(+10.9%)
Dec 2021
$37.42 B(+40.6%)
$12.01 B(+21.7%)
$37.42 B(+14.0%)
Sep 2021
-
$9.87 B(+20.0%)
$32.82 B(+11.1%)
Jun 2021
-
$8.22 B(+12.3%)
$29.53 B(+7.1%)
Mar 2021
-
$7.32 B(-1.2%)
$27.58 B(+3.6%)
Dec 2020
$26.62 B(+9.2%)
$7.41 B(+12.6%)
$26.62 B(+2.9%)
Sep 2020
-
$6.58 B(+4.8%)
$25.87 B(+0.7%)
Jun 2020
-
$6.28 B(-1.2%)
$25.70 B(+1.8%)
Mar 2020
-
$6.35 B(-4.7%)
$25.25 B(+3.5%)
Dec 2019
$24.38 B(+10.4%)
$6.66 B(+4.0%)
$24.38 B(+1.0%)
Sep 2019
-
$6.41 B(+10.0%)
$24.14 B(+4.6%)
Jun 2019
-
$5.82 B(+6.0%)
$23.07 B(+3.0%)
Mar 2019
-
$5.49 B(-14.4%)
$22.40 B(+1.4%)
Dec 2018
$22.09 B(-1.7%)
$6.42 B(+20.2%)
$22.09 B(+3.0%)
Sep 2018
-
$5.34 B(+3.6%)
$21.45 B(-4.0%)
Jun 2018
-
$5.16 B(-0.4%)
$22.34 B(+0.5%)
Mar 2018
-
$5.18 B(-10.4%)
$22.24 B(-1.0%)
Dec 2017
$22.46 B(-2.3%)
$5.78 B(-7.3%)
$22.46 B(+0.9%)
Sep 2017
-
$6.23 B(+23.4%)
$22.27 B(+2.5%)
Jun 2017
-
$5.05 B(-6.5%)
$21.74 B(-2.5%)
Mar 2017
-
$5.41 B(-3.2%)
$22.29 B(-3.1%)
Dec 2016
$23.00 B(-6.9%)
$5.58 B(-2.0%)
$23.00 B(-3.4%)
Sep 2016
-
$5.70 B(+1.7%)
$23.82 B(-1.0%)
Jun 2016
-
$5.60 B(-8.4%)
$24.06 B(-2.8%)
Mar 2016
-
$6.12 B(-4.4%)
$24.77 B(+0.2%)
Dec 2015
$24.71 B(-6.9%)
$6.40 B(+7.6%)
$24.71 B(-1.3%)
Sep 2015
-
$5.95 B(-5.7%)
$25.02 B(-2.6%)
Jun 2015
-
$6.31 B(+4.1%)
$25.69 B(-1.7%)
Mar 2015
-
$6.06 B(-9.8%)
$26.14 B(-1.5%)
Dec 2014
$26.55 B(+2.9%)
$6.72 B(+1.6%)
$26.55 B(-0.8%)
Sep 2014
-
$6.61 B(-2.3%)
$26.77 B(+1.4%)
Jun 2014
-
$6.76 B(+4.7%)
$26.41 B(+2.0%)
Mar 2014
-
$6.46 B(-6.9%)
$25.88 B(+0.3%)
Dec 2013
$25.81 B(-7.7%)
$6.94 B(+11.0%)
$25.81 B(-1.3%)
Sep 2013
-
$6.25 B(+0.3%)
$26.15 B(-1.6%)
Jun 2013
-
$6.23 B(-2.4%)
$26.58 B(-1.6%)
Mar 2013
-
$6.38 B(-12.3%)
$27.01 B(-3.4%)
Dec 2012
$27.97 B(-16.7%)
$7.28 B(+9.0%)
$27.97 B(-4.7%)
Sep 2012
-
$6.68 B(+0.3%)
$29.35 B(-5.0%)
Jun 2012
-
$6.66 B(-9.4%)
$30.88 B(-5.4%)
Mar 2012
-
$7.35 B(-15.1%)
$32.65 B(-2.8%)
Dec 2011
$33.59 B(+1.0%)
$8.66 B(+5.4%)
$33.59 B(+0.1%)
Sep 2011
-
$8.21 B(-2.6%)
$33.55 B(+0.9%)
Jun 2011
-
$8.43 B(+1.7%)
$33.24 B(+0.8%)
Mar 2011
-
$8.29 B(-3.8%)
$32.98 B(-0.9%)
Dec 2010
$33.27 B(+1.4%)
$8.62 B(+9.1%)
$33.27 B(-1.0%)
Sep 2010
-
$7.90 B(-3.4%)
$33.60 B(-0.9%)
Jun 2010
-
$8.18 B(-4.6%)
$33.90 B(+0.7%)
Mar 2010
-
$8.58 B(-4.1%)
$33.68 B(+2.7%)
Dec 2009
$32.80 B(+3.8%)
$8.95 B(+9.1%)
$32.80 B(+2.3%)
Sep 2009
-
$8.20 B(+3.0%)
$32.05 B(+1.3%)
Jun 2009
-
$7.96 B(+3.3%)
$31.63 B(+0.0%)
Mar 2009
-
$7.70 B(-6.0%)
$31.63 B(+0.1%)
Dec 2008
$31.60 B
$8.19 B(+5.4%)
$31.60 B(+0.1%)
DateAnnualQuarterlyTTM
Sep 2008
-
$7.78 B(-2.3%)
$31.58 B(+2.0%)
Jun 2008
-
$7.96 B(+3.6%)
$30.95 B(+2.3%)
Mar 2008
-
$7.68 B(-6.0%)
$30.27 B(+2.4%)
Dec 2007
$29.56 B(+11.6%)
$8.17 B(+14.3%)
$29.56 B(+3.6%)
Sep 2007
-
$7.15 B(-1.7%)
$28.54 B(+2.3%)
Jun 2007
-
$7.27 B(+4.4%)
$27.91 B(+2.4%)
Mar 2007
-
$6.97 B(-2.6%)
$27.26 B(+3.0%)
Dec 2006
$26.48 B(+10.5%)
$7.15 B(+9.8%)
$26.48 B(+3.4%)
Sep 2006
-
$6.52 B(-1.6%)
$25.61 B(+2.9%)
Jun 2006
-
$6.63 B(+7.2%)
$24.88 B(+2.0%)
Mar 2006
-
$6.18 B(-1.7%)
$24.39 B(+1.8%)
Dec 2005
$23.95 B(+11.8%)
$6.29 B(+8.6%)
$23.95 B(+2.1%)
Sep 2005
-
$5.79 B(-5.6%)
$23.46 B(+2.3%)
Jun 2005
-
$6.13 B(+6.8%)
$22.94 B(+3.8%)
Mar 2005
-
$5.74 B(-1.0%)
$22.09 B(+3.1%)
Dec 2004
$21.43 B(+13.7%)
$5.80 B(+10.1%)
$21.43 B(+4.5%)
Sep 2004
-
$5.26 B(-0.4%)
$20.50 B(+2.4%)
Jun 2004
-
$5.29 B(+4.2%)
$20.01 B(+4.3%)
Mar 2004
-
$5.07 B(+4.1%)
$19.18 B(+1.8%)
Dec 2003
$18.85 B(+5.6%)
$4.88 B(+2.0%)
$18.85 B(+0.8%)
Sep 2003
-
$4.78 B(+7.3%)
$18.69 B(+1.7%)
Jun 2003
-
$4.45 B(-6.1%)
$18.38 B(+0.8%)
Mar 2003
-
$4.74 B(+0.5%)
$18.24 B(+2.2%)
Dec 2002
$17.84 B(+8.3%)
$4.72 B(+5.6%)
$17.84 B(+1.6%)
Sep 2002
-
$4.47 B(+3.6%)
$17.56 B(+3.0%)
Jun 2002
-
$4.31 B(-0.8%)
$17.05 B(+1.3%)
Mar 2002
-
$4.35 B(-2.1%)
$16.84 B(+2.2%)
Dec 2001
$16.48 B(-9.0%)
$4.44 B(+12.4%)
$16.47 B(-11.0%)
Sep 2001
-
$3.95 B(-3.6%)
$18.50 B(+1.0%)
Jun 2001
-
$4.10 B(+3.0%)
$18.33 B(+0.7%)
Mar 2001
-
$3.98 B(-38.6%)
$18.21 B(+0.5%)
Dec 2000
$18.12 B(+19.7%)
$6.48 B(+71.6%)
$18.12 B(+34.7%)
Sep 2000
-
$3.77 B(-5.1%)
$13.45 B(-3.6%)
Jun 2000
-
$3.98 B(+2.3%)
$13.96 B(-3.8%)
Mar 2000
-
$3.89 B(+114.5%)
$14.50 B(-4.2%)
Dec 1999
$15.13 B(+33.7%)
$1.81 B(-57.7%)
$15.13 B(-12.9%)
Sep 1999
-
$4.28 B(-5.4%)
$17.38 B(+12.6%)
Jun 1999
-
$4.52 B(0.0%)
$15.43 B(+9.4%)
Mar 1999
-
$4.52 B(+11.4%)
$14.10 B(+17.5%)
Dec 1998
$11.32 B(+31.8%)
$4.06 B(+74.2%)
$12.00 B(+17.3%)
Sep 1998
-
$2.33 B(-27.0%)
$10.23 B(+2.3%)
Jun 1998
-
$3.19 B(+32.0%)
$10.00 B(+10.0%)
Mar 1998
-
$2.42 B(+5.7%)
$9.09 B(+1.5%)
Dec 1997
$8.59 B(-6.5%)
$2.29 B(+9.0%)
$8.96 B(-20.2%)
Sep 1997
-
$2.10 B(-8.1%)
$11.22 B(-1.9%)
Jun 1997
-
$2.28 B(0.0%)
$11.44 B(+0.0%)
Mar 1997
-
$2.28 B(-49.9%)
$11.43 B(+0.0%)
Dec 1996
$9.18 B(+21.3%)
$4.56 B(+97.0%)
$11.43 B(+32.4%)
Sep 1996
-
$2.31 B(+1.5%)
$8.63 B(+4.6%)
Jun 1996
-
$2.28 B(0.0%)
$8.26 B(+3.3%)
Mar 1996
-
$2.28 B(+29.2%)
$7.99 B(+3.4%)
Dec 1995
$7.57 B(+8.1%)
$1.76 B(-8.9%)
$7.73 B(-0.8%)
Sep 1995
-
$1.94 B(-4.1%)
$7.80 B(+2.4%)
Jun 1995
-
$2.02 B(-0.0%)
$7.61 B(+2.4%)
Mar 1995
-
$2.02 B(+10.4%)
$7.43 B(+2.5%)
Dec 1994
$7.00 B(+6.6%)
$1.83 B(+4.2%)
$7.25 B(+4.2%)
Sep 1994
-
$1.75 B(-4.6%)
$6.96 B(+3.2%)
Jun 1994
-
$1.84 B(0.0%)
$6.74 B(+1.3%)
Mar 1994
-
$1.84 B(+19.8%)
$6.66 B(+1.3%)
Dec 1993
$6.57 B(+8.8%)
$1.53 B(-0.2%)
$6.57 B(+30.5%)
Sep 1993
-
$1.54 B(-12.1%)
$5.03 B(+44.0%)
Jun 1993
-
$1.75 B(0.0%)
$3.50 B(+100.0%)
Mar 1993
-
$1.75 B
$1.75 B
Dec 1992
$6.03 B(-17.9%)
-
-
Dec 1991
$7.35 B(+0.0%)
-
-
Dec 1990
$7.35 B
-
-

FAQ

  • What is AstraZeneca annual revenue?
  • What is the all time high annual revenue for AstraZeneca?
  • What is AstraZeneca annual revenue year-on-year change?
  • What is AstraZeneca quarterly revenue?
  • What is the all time high quarterly revenue for AstraZeneca?
  • What is AstraZeneca quarterly revenue year-on-year change?
  • What is AstraZeneca TTM revenue?
  • What is the all time high TTM revenue for AstraZeneca?
  • What is AstraZeneca TTM revenue year-on-year change?

What is AstraZeneca annual revenue?

The current annual revenue of AZN is $54.07 B

What is the all time high annual revenue for AstraZeneca?

AstraZeneca all-time high annual revenue is $54.07 B

What is AstraZeneca annual revenue year-on-year change?

Over the past year, AZN annual revenue has changed by +$8.26 B (+18.03%)

What is AstraZeneca quarterly revenue?

The current quarterly revenue of AZN is $13.56 B

What is the all time high quarterly revenue for AstraZeneca?

AstraZeneca all-time high quarterly revenue is $13.56 B

What is AstraZeneca quarterly revenue year-on-year change?

Over the past year, AZN quarterly revenue has changed by +$2.07 B (+18.04%)

What is AstraZeneca TTM revenue?

The current TTM revenue of AZN is $51.21 B

What is the all time high TTM revenue for AstraZeneca?

AstraZeneca all-time high TTM revenue is $51.21 B

What is AstraZeneca TTM revenue year-on-year change?

Over the past year, AZN TTM revenue has changed by +$6.21 B (+13.81%)